未登录

K

Kieran Rothnie

University of London

H指数:19

被引数:1,726

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort study

描述哮喘患者中度急性加重负担的Extended Salford Lung Study（Ext-SLS）扩展萨尔福德肺脏研究：一项回顾性队列研究

RESPIRATORY RESEARCH

IF5

2025-03-290

OA

Burden of illness among patients with asthma prescribed inhaled corticosteroids/long-acting β2-agonists

NPJ PRIMARY CARE RESPIRATORY MEDICINE

IF4.7

2025-02-260

OAAI

Development of claims and EHR-based algorithm for refractory chronic cough: CLeaR-CC

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study ( vol 40 , pg 4857 , 2023)

ADVANCES IN THERAPY

IF4

2024-10-250

OAAI

Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study

BMJ OPEN RESPIRATORY RESEARCH

IF3.4

2024-05-213

OAAI

Frequency and economic burden of exacerbations in inhaled corticosteroid/ long-acting beta-agonist-treated patients with asthma: A retrospective US claims study

RESPIRATORY MEDICINE

IF3.1

2024-05-010

PRE

Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US

RESPIRATORY MEDICINE

IF3.1

2024-05-010

PRE

Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study (vol 40, pg 4857, 2023)

ADVANCES IN THERAPY

IF4

2023-12-011

OAAI

Adherence to single and multiple inhaler triple therapies among patients with COPD in the real world in Japan

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Characteristics and treatment pathways of COPD patients initiating single-inhaler dual or triple therapy in England

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Validation of an EMR derived algorithm to identify moderate asthma exacerbations in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Persistence to inhaled long-acting maintenance therapy in patients with COPD in UK routine clinical practice

在英国常规临床实践中，COPD患者持续吸入长效维持治疗

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

IMPACT OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON RESPIRATORY MEDICATION DISPENSING IN ASTHMA IN THE UNITED STATES (2018-2022): A POPULATION-BASED STUDY

IF8.6

2023-10-010

PRE

IMPACT OF CORONAVIRUS DISEASE 2019 ON ADHERENCE TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA MAINTENANCE MEDICATIONS IN THE UNITED STATES

IF8.6

2023-10-010

PRE

IMPACT OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON RESPIRATORY MEDICATION DISPENSING IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED STATES: A POPULATION-BASED STUDY

IF8.6

2023-10-010

OA

IMPACT OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON LUNG FUNCTION TESTING IN THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA POPULATION: A POPULATION-BASED STUDY

IF8.6

2023-10-010

OA

Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study

ADVANCES IN THERAPY

IF4

2023-09-127

OAAI

Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England

IF7.7

2023-06-165

OA

Identifying risk of first COPD exacerbation in COPD patients in GOLD group A/B in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2022-12-010

PRE

COVID-19 incidence and hospitalization in routine clinical practice among COPD patients in England in 2020

EUROPEAN RESPIRATORY JOURNAL

IF21

2022-12-011

PRE